Biotech Outsourcing Strategies (BOS Basel 2024) is a partnering event for small molecules, CMC outsourcing and biologics.
Biotech Outsourcing Strategies (BOS Basel 2024) covers topics such as:
- Small molecule and biologics
- Perspectives from different types of outsourcing organisation from the virtual biotech to the multi-national pharma and the international CROs
- Drug Substance, Drug Product and Regulatory/QA
Biotech Outsourcing Strategies (BOS Basel 2024) brings together senior attendees involved or interested in CMC outsourcing from biotechonology and pharmaceutical companies, CMOs and CROs , including:
- Directors of CMC
- VPs of CMC
- CMC Outsourcing Managers
- Heads of CMC
- Outsourcing Managers
- CMC Project Managers
- VPs/Directors/Heads of External Manufacturing
- VPs/Directors/Heads of of Contract Manufacturing
- Heads of Chemistry
- Programme Managers
- VPs of Business Development
- Sourcing Managers
- Business Development Managers
- Heads of Business Development
- Sales Managers
- Account Managers
- Corporate Management
- Marketing Managers
- Owners/MD of SME CROs/CMOs
